Article 25 Sep 2024 Eli Lilly Files Suit Challenging The FDA's Drug Classification Of Retatrutide United States Healthcare
Article 21 Aug 2024 FDA Seeks Input On Biosimilar Product Development Guidance United States Healthcare
Article 07 Jun 2024 FDA Launches Support For Clinical Trials Advancing Rare Disease Therapeutics (START) Pilot Program United States Healthcare
Article 09 May 2024 FDA Updates Draft Guidance On Promotional Communications Of Prescription Biologics And Biosimilars United States Healthcare
Article 05 Mar 2024 Alvotech Announces More Settlements And Expected Launch Dates Regarding Biosimilar To STELARA (Ustekinumab), AVT04 United States Healthcare
Article 30 Jan 2024 Alvotech And STADA Obtain Approval In Europe For Ustekinumab Biosimilar, UZPRUVO European Union Healthcare